Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Green Cap Health vs LillyDirect Foundayo

Green Cap Health
Graded #258

Lower grade

vs+4
LillyDirect Foundayo
Graded #165

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 63.2/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGreen Cap Health +2
74
72
Dose & formulationGreen Cap Health +5
64
59
Clinical oversightLillyDirect Foundayo +10
68
78
Labs & monitoringEven
52
52
FulfillmentLillyDirect Foundayo +24
56
80
Contract termsLillyDirect Foundayo +8
47
55
Green Cap Health · left barLillyDirect Foundayo · right bar

The numbers

MetricGreen Cap HealthLillyDirect Foundayo
WeighScore63.2/10067.2/100
GradeCC
Scorecard rank#258#165
Semaglutide$129/mo (6-month plan, compounded)Not disclosed
Tirzepatide$199/mo (6-month plan, compounded)Not disclosed
Coverage1 stateAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Green Cap Health

Graded #258 · C

Strengths

  • Vertically integrated: the prescribing practice and the compounding pharmacy are the same company, so the supply chain is short and named
  • Same-day provider review and 1-3 day discreet shipping
  • The full commitment ladder is published, so the month-to-month rate and the six-month rate can be compared directly

Where it loses points

  • The advertised $2.63-a-day and $79 first-month figures do not correspond to any purchasable plan; the cheapest real rates are $129/mo semaglutide and $199/mo tirzepatide, both on six-month commitments, and month-to-month is $179 and $279
  • The terms disclose a separate Weight Management Program Membership Fee, charged periodically on top of the plan and revealed only during checkout — it appears on no product page
  • The terms also state recurring fees are charged in advance without seeking any additional authorisation
  • Service is Texas-only, so nothing here is available to a reader outside that state
  • The site's terms link out to lifemd.com's terms — the legal text is another company's
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard